These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 696)

  • 1. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
    Wolf P; Feller K; Femmer K
    Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
    Coleman AJ; Leary WP; Asmal AC
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):64-79. PubMed ID: 4149207
    [No Abstract]   [Full Text] [Related]  

  • 3. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular response in hyperthyroidism. The influence of adrenergic-receptor blockade.
    Pietras RJ; Real MA; Poticha GS; Bronsky D; Waldstein SS
    Arch Intern Med; 1972 Mar; 129(3):426-9. PubMed ID: 4401571
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the action of talinolol (Cordanum, 02-115) on the coronary blood circulation].
    Modersohn D; Femmer K
    Pharmazie; 1975 Oct; 30(10):652-5. PubMed ID: 689
    [No Abstract]   [Full Text] [Related]  

  • 7. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO; Fiehring H; Oltmanns G; Femmer K
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 9. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].
    Gloger K
    Arzneimittelforschung; 1975 Aug; 25(8):1300-3. PubMed ID: 241365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a new beta-receptor blocking substance on human hemodynamics and metabolism].
    Niessner H; Lujf A; Moser K
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):277-81. PubMed ID: 4394123
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
    Klempt HW; Bender F
    Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic effects of adrenergic beta-receptor blocking agents.
    Sannerstedt R
    Adv Clin Pharmacol; 1976; 11():70-8. PubMed ID: 25571
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
    Weiss L; Lundgren Y; Folkow B
    Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of isoproterenol in cardiac surgery.
    Beregovich J; Reicher-Reiss H; Kunstadt D; Grishman A
    J Thorac Cardiovasc Surg; 1971 Dec; 62(6):957-64. PubMed ID: 5129399
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardioselective beta receptor blockade in acute myocardial infarct with talinolol].
    Assmann I; Fiehring H; Oltmanns G; Kulick B; Kretzschmar E
    Z Gesamte Inn Med; 1981 Sep; 36(18):637-44. PubMed ID: 6118980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on concurrent alpha- and beta-adrenoceptor blocking action of S-596 (arotinolol).
    Takekoshi N; Murakami E; Matsui S; Murakami H; Emoto J; Hashimoto A
    Jpn Heart J; 1983 Nov; 24(6):925-33. PubMed ID: 6200619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.